MetaVia

MTVANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.918 M

$1.05 -21.64%

Close of 6 Nov 2026

As of 6 Nov 2026, MetaVia (MTVA) has a market capitalization of $6.92M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$13.0M

Loss-making

Shares outstanding

6,588,101

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#434Aprea TherapeuticsAPRE$7.03M
#435Universe PharmaceuticalsUPC$6.98M
#436MetaViaMTVA$6.92M
#437ImmuronIMRN$6.70M
#438Ensysce BiosciencesENSC$6.65M

What if MetaVia were worth as much as…

Open the what-if tool →

Gold $28.2T

$4,286,041

Per share 4,081,944× higher

Bitcoin $1.53T

$231,910.24

Per share 220,867× higher

Apple $5.02T

$761,339.67

Per share 725,085× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for MetaVia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.